Literature DB >> 26037171

Novel imaging findings in two cases of biotinidase deficiency-a treatable metabolic disorder.

Maya Dattatraya Bhat1, P S Bindu, Rita Christopher, Chandrajit Prasad, Abha Verma.   

Abstract

Biotinidase deficiency is one of the few treatable inborn errors of metabolism. We describe unique MRI features in two patients with biotinidase deficiency. Brain MRI in case one demonstrated symmetrical diffusion restriction in bilateral hippocampi, parahippocampal gyri, central tegmental tracts, and cerebellar white matter besides other structures that have been reported previously. The second patient was noted to have bilateral symmetrical T2 hyperintensities involving the anterior, lateral and posterior columns of the entire spinal cord on MRI. Knowledge of the varied MRI features of biotinidase deficiency will aid the prompt diagnosis and treatment of a potentially disabling illness, especially in countries where newborn screening is not routinely performed.

Entities:  

Mesh:

Year:  2015        PMID: 26037171     DOI: 10.1007/s11011-015-9690-0

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  8 in total

1.  Brain diffusion-weighted and diffusion tensor imaging findings in an infant with biotinidase deficiency.

Authors:  J P Soares-Fernandes; Z Magalhães; J F Rocha; A J Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  2009-06-09       Impact factor: 3.825

2.  Worldwide survey of neonatal screening for biotinidase deficiency.

Authors:  B Wolf
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

Review 3.  Biotinidase deficiency presenting as recurrent myelopathy in a 7-year-old boy and a review of the literature.

Authors:  Sarbani Raha; Vrajesh Udani
Journal:  Pediatr Neurol       Date:  2011-10       Impact factor: 3.372

4.  Delayed-onset profound biotinidase deficiency.

Authors:  B Wolf; R J Pomponio; K J Norrgard; I T Lott; E R Baumgartner; T Suormala; V T Ramaekers; T Coskun; A Tokatli; I Ozalp; J Hymes
Journal:  J Pediatr       Date:  1998-02       Impact factor: 4.406

5.  Phenotypic variation in biotinidase deficiency.

Authors:  B Wolf; R E Grier; R J Allen; S I Goodman; C L Kien; W D Parker; D M Howell; D L Hurst
Journal:  J Pediatr       Date:  1983-08       Impact factor: 4.406

6.  Intermittent ataxia and immunodeficiency with multiple carboxylase deficiencies: a biotin-responsive disorder.

Authors:  J E Sander; N Malamud; M J Cowan; S Packman; A J Amman; D W Wara
Journal:  Ann Neurol       Date:  1980-11       Impact factor: 10.422

7.  Biotinidase deficiency: a reversible metabolic encephalopathy. Neuroimaging and MR spectroscopic findings in a series of four patients.

Authors:  Shrinivas Desai; Karthik Ganesan; Anaita Hegde
Journal:  Pediatr Radiol       Date:  2008-06-11

8.  Neuropathology of biotinidase deficiency.

Authors:  M Honavar; I Janota; B G Neville; R A Chalmers
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

  8 in total
  4 in total

1.  Status of Newborn Screening and Inborn Errors of Metabolism in India.

Authors:  Seema Kapoor; B K Thelma
Journal:  Indian J Pediatr       Date:  2018-05-07       Impact factor: 1.967

Review 2.  Biotinidase Deficiency: Prevalence, Impact And Management Strategies.

Authors:  Ebru Canda; Sema Kalkan Uçar; Mahmut Çoker
Journal:  Pediatric Health Med Ther       Date:  2020-05-04

3.  Late Onset Subacute Profound Biotinidase Deficiency Caused by a Novel Homozygous Variant c.466-3T>G in the BTD Gene.

Authors:  Kaustubh Mohite; Karthik Vijay Nair; Anilkumar Sapare; Venkatraman Bhat; Anju Shukla; Minal Kekatpure; Siddaramappa J Patil
Journal:  Indian J Pediatr       Date:  2022-01-14       Impact factor: 5.319

4.  Severe Distal Motor Involvement in a Non-compliant Adult With Biotinidase Deficiency: The Necessity of Life-Long Biotin Therapy.

Authors:  Géraldine Van Winckel; Diana Ballhausen; Barry Wolf; Melinda Procter; Rong Mao; Patricie Burda; Davide Strambo; Thierry Kuntzer; Christel Tran
Journal:  Front Neurol       Date:  2020-10-26       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.